Zilucoplan bioequivalence study comparing prefilled syringe vs autoinjector in healthy volunteers

Phase 1, randomised, open-label trial of zilucoplan (2 arms), sponsored by UCB. Primary endpoints: Area Under the Plasma Concentration-time Curve From Time Zero to Infinity at 35 days, Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration at 35 days and 1 more. Started Aug 2024; status: completed.